Post by
subaru1i on Mar 13, 2024 8:06am
Why was ANVISA approval for LABS so important?
It enables LABS now to provide additional production support capacity for Avicanna's plans for all of South America....additional pharmaceutical production capacity, not only for Canadian market.
Imho, the biggest wild card globally is the race China is in developing pharmaceutical cannabis compounds as well because that 'technology' can easily become part of their Silk Road innitiatives combining infrastructure, manufacturing and health care into that package.
Comment by
okgonow on Mar 13, 2024 10:02am
give your head a shake they have south american partners producing the CBD for them , at what i am sure is a fraction of the cost a canadian company can supply it for!!!! if they get aproval for Canada or the US then LABS would be the go to supplier